Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Stefan Aebi(University of Lucerne), Aron Goldhirsch(Unknown), Shari Gelber(Frontier Science & Technology Research Foundation), Jurij Lindtner(International Breast Cancer Study Group), Beat Thürlimann(University of St.Gallen), Diana Crivellari(Centro di Riferimento Oncologico), C.-M. Rudenstam(Kantonsspital St. Gallen), Coates As(University of Sydney), RD Gelber(Harvard University), J. Collins(International Breast Cancer Study Group), I. D. Werner(Groote Schuur Hospital), Monica Castiglione‐Gertsch(University of Geneva), H. Cortés-Funes(Centre Hospitalier René-Dubos), Edda Simoncini(International Breast Cancer Study Group)
Cited by 286
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
|UCL Discovery (University College London)|1997|1k